udp glc Search Results


ugdh  (Proteintech)
93
Proteintech ugdh
Fig. 7. ROS activate the PI3K/AKT pathway, regulating <t>the</t> <t>UGDH-EEF1A2-PRDX1</t> axis to promote chemoresistance. (A) KEGG pathway enrichment of DEGs in UGDH-knockdown SW620 cells (n = 3 replicates). (B) Western blot of PI3K/AKT pathway proteins in HCT8 cells ± LY294002 (10 μM, 48 h, n = 3). (C) PI3K/AKT phosphorylation in HCT8 control and shUGDH cells ± 5-FU (n = 3). (D) UGDH and PI3K/AKT activation in HCT8 cells treated with H2O2 (0–200 μM, 24 h, n = 3). (E) Time-dependent UGDH activation in HCT8 cells treated with 15 μM 5-FU (0–96 h). (n = 3). (F) Western blot of PI3K/AKT pathway proteins in HCT8 cells ± LY294002 (10 μM, n = 3)/± NAC (750 μМ, n = 3). Data are mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
Ugdh, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/udp+glc/UGDH+Antibody/pm40311992-81-6-7
Average 93 stars, based on 1 article reviews
ugdh - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier
uridine  (Valiant Co Ltd)
94
Valiant Co Ltd uridine
Fig. 7. ROS activate the PI3K/AKT pathway, regulating <t>the</t> <t>UGDH-EEF1A2-PRDX1</t> axis to promote chemoresistance. (A) KEGG pathway enrichment of DEGs in UGDH-knockdown SW620 cells (n = 3 replicates). (B) Western blot of PI3K/AKT pathway proteins in HCT8 cells ± LY294002 (10 μM, 48 h, n = 3). (C) PI3K/AKT phosphorylation in HCT8 control and shUGDH cells ± 5-FU (n = 3). (D) UGDH and PI3K/AKT activation in HCT8 cells treated with H2O2 (0–200 μM, 24 h, n = 3). (E) Time-dependent UGDH activation in HCT8 cells treated with 15 μM 5-FU (0–96 h). (n = 3). (F) Western blot of PI3K/AKT pathway proteins in HCT8 cells ± LY294002 (10 μM, n = 3)/± NAC (750 μМ, n = 3). Data are mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
Uridine, supplied by Valiant Co Ltd, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/udp+glc/Uridine-5'-diphosphoglucose/bio_rxiv__64898__2025__12__06__692756-249-26-29
Average 94 stars, based on 1 article reviews
uridine - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier
uridine diphosphate glucose (udp-glc)  (NEN Life Science)
90
NEN Life Science uridine diphosphate glucose (udp-glc)
Fig. 7. ROS activate the PI3K/AKT pathway, regulating <t>the</t> <t>UGDH-EEF1A2-PRDX1</t> axis to promote chemoresistance. (A) KEGG pathway enrichment of DEGs in UGDH-knockdown SW620 cells (n = 3 replicates). (B) Western blot of PI3K/AKT pathway proteins in HCT8 cells ± LY294002 (10 μM, 48 h, n = 3). (C) PI3K/AKT phosphorylation in HCT8 control and shUGDH cells ± 5-FU (n = 3). (D) UGDH and PI3K/AKT activation in HCT8 cells treated with H2O2 (0–200 μM, 24 h, n = 3). (E) Time-dependent UGDH activation in HCT8 cells treated with 15 μM 5-FU (0–96 h). (n = 3). (F) Western blot of PI3K/AKT pathway proteins in HCT8 cells ± LY294002 (10 μM, n = 3)/± NAC (750 μМ, n = 3). Data are mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
Uridine Diphosphate Glucose (Udp Glc), supplied by NEN Life Science, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/udp+glc/uridine+diphosphate+glucose++udp+glc+/pm15590150-43-0-7
Average 90 stars, based on 1 article reviews
uridine diphosphate glucose (udp-glc) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
ultra-pure udp-glc  (Promega)
90
Promega ultra-pure udp-glc
Fig. 7. ROS activate the PI3K/AKT pathway, regulating <t>the</t> <t>UGDH-EEF1A2-PRDX1</t> axis to promote chemoresistance. (A) KEGG pathway enrichment of DEGs in UGDH-knockdown SW620 cells (n = 3 replicates). (B) Western blot of PI3K/AKT pathway proteins in HCT8 cells ± LY294002 (10 μM, 48 h, n = 3). (C) PI3K/AKT phosphorylation in HCT8 control and shUGDH cells ± 5-FU (n = 3). (D) UGDH and PI3K/AKT activation in HCT8 cells treated with H2O2 (0–200 μM, 24 h, n = 3). (E) Time-dependent UGDH activation in HCT8 cells treated with 15 μM 5-FU (0–96 h). (n = 3). (F) Western blot of PI3K/AKT pathway proteins in HCT8 cells ± LY294002 (10 μM, n = 3)/± NAC (750 μМ, n = 3). Data are mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
Ultra Pure Udp Glc, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/udp+glc/ultra+pure+udp+glc/pmc08233153-225-9-11
Average 90 stars, based on 1 article reviews
ultra-pure udp-glc - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
udp-glc  (FUJIFILM)
90
FUJIFILM udp-glc
Fig. 7. ROS activate the PI3K/AKT pathway, regulating <t>the</t> <t>UGDH-EEF1A2-PRDX1</t> axis to promote chemoresistance. (A) KEGG pathway enrichment of DEGs in UGDH-knockdown SW620 cells (n = 3 replicates). (B) Western blot of PI3K/AKT pathway proteins in HCT8 cells ± LY294002 (10 μM, 48 h, n = 3). (C) PI3K/AKT phosphorylation in HCT8 control and shUGDH cells ± 5-FU (n = 3). (D) UGDH and PI3K/AKT activation in HCT8 cells treated with H2O2 (0–200 μM, 24 h, n = 3). (E) Time-dependent UGDH activation in HCT8 cells treated with 15 μM 5-FU (0–96 h). (n = 3). (F) Western blot of PI3K/AKT pathway proteins in HCT8 cells ± LY294002 (10 μM, n = 3)/± NAC (750 μМ, n = 3). Data are mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
Udp Glc, supplied by FUJIFILM, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/udp+glc/udp+glc/bio_rxiv__2023__05__22__541790-221-0-11
Average 90 stars, based on 1 article reviews
udp-glc - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
udp-[13c]glc-1-p  (Omicron Biochemicals Inc)
90
Omicron Biochemicals Inc udp-[13c]glc-1-p
Fig. 7. ROS activate the PI3K/AKT pathway, regulating <t>the</t> <t>UGDH-EEF1A2-PRDX1</t> axis to promote chemoresistance. (A) KEGG pathway enrichment of DEGs in UGDH-knockdown SW620 cells (n = 3 replicates). (B) Western blot of PI3K/AKT pathway proteins in HCT8 cells ± LY294002 (10 μM, 48 h, n = 3). (C) PI3K/AKT phosphorylation in HCT8 control and shUGDH cells ± 5-FU (n = 3). (D) UGDH and PI3K/AKT activation in HCT8 cells treated with H2O2 (0–200 μM, 24 h, n = 3). (E) Time-dependent UGDH activation in HCT8 cells treated with 15 μM 5-FU (0–96 h). (n = 3). (F) Western blot of PI3K/AKT pathway proteins in HCT8 cells ± LY294002 (10 μM, n = 3)/± NAC (750 μМ, n = 3). Data are mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
Udp [13c]Glc 1 P, supplied by Omicron Biochemicals Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/udp+glc/udp++13c+glc+1+p/10__1074_slash_jbc__m111__287367-111-14-15
Average 90 stars, based on 1 article reviews
udp-[13c]glc-1-p - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
udp-glc dehydrogenase  (Merck KGaA)
90
Merck KGaA udp-glc dehydrogenase
Fig. 7. ROS activate the PI3K/AKT pathway, regulating <t>the</t> <t>UGDH-EEF1A2-PRDX1</t> axis to promote chemoresistance. (A) KEGG pathway enrichment of DEGs in UGDH-knockdown SW620 cells (n = 3 replicates). (B) Western blot of PI3K/AKT pathway proteins in HCT8 cells ± LY294002 (10 μM, 48 h, n = 3). (C) PI3K/AKT phosphorylation in HCT8 control and shUGDH cells ± 5-FU (n = 3). (D) UGDH and PI3K/AKT activation in HCT8 cells treated with H2O2 (0–200 μM, 24 h, n = 3). (E) Time-dependent UGDH activation in HCT8 cells treated with 15 μM 5-FU (0–96 h). (n = 3). (F) Western blot of PI3K/AKT pathway proteins in HCT8 cells ± LY294002 (10 μM, n = 3)/± NAC (750 μМ, n = 3). Data are mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
Udp Glc Dehydrogenase, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/udp+glc/udp+glc+dehydrogenase/pm19850285-70-76-78
Average 90 stars, based on 1 article reviews
udp-glc dehydrogenase - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
phosphorothioate analogues of udp-glc unlabeled  (DuPont de Nemours)
90
DuPont de Nemours phosphorothioate analogues of udp-glc unlabeled
Fig. 7. ROS activate the PI3K/AKT pathway, regulating <t>the</t> <t>UGDH-EEF1A2-PRDX1</t> axis to promote chemoresistance. (A) KEGG pathway enrichment of DEGs in UGDH-knockdown SW620 cells (n = 3 replicates). (B) Western blot of PI3K/AKT pathway proteins in HCT8 cells ± LY294002 (10 μM, 48 h, n = 3). (C) PI3K/AKT phosphorylation in HCT8 control and shUGDH cells ± 5-FU (n = 3). (D) UGDH and PI3K/AKT activation in HCT8 cells treated with H2O2 (0–200 μM, 24 h, n = 3). (E) Time-dependent UGDH activation in HCT8 cells treated with 15 μM 5-FU (0–96 h). (n = 3). (F) Western blot of PI3K/AKT pathway proteins in HCT8 cells ± LY294002 (10 μM, n = 3)/± NAC (750 μМ, n = 3). Data are mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
Phosphorothioate Analogues Of Udp Glc Unlabeled, supplied by DuPont de Nemours, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/udp+glc/phosphorothioate+analogues+of+udp+glc+unlabeled/pm02162150-34-4-25
Average 90 stars, based on 1 article reviews
phosphorothioate analogues of udp-glc unlabeled - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
udp-glc  (Informa UK Limited)
90
Informa UK Limited udp-glc
Fig. 7. ROS activate the PI3K/AKT pathway, regulating <t>the</t> <t>UGDH-EEF1A2-PRDX1</t> axis to promote chemoresistance. (A) KEGG pathway enrichment of DEGs in UGDH-knockdown SW620 cells (n = 3 replicates). (B) Western blot of PI3K/AKT pathway proteins in HCT8 cells ± LY294002 (10 μM, 48 h, n = 3). (C) PI3K/AKT phosphorylation in HCT8 control and shUGDH cells ± 5-FU (n = 3). (D) UGDH and PI3K/AKT activation in HCT8 cells treated with H2O2 (0–200 μM, 24 h, n = 3). (E) Time-dependent UGDH activation in HCT8 cells treated with 15 μM 5-FU (0–96 h). (n = 3). (F) Western blot of PI3K/AKT pathway proteins in HCT8 cells ± LY294002 (10 μM, n = 3)/± NAC (750 μМ, n = 3). Data are mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
Udp Glc, supplied by Informa UK Limited, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/udp+glc/udp+glc/pm31888381-10-6-1
Average 90 stars, based on 1 article reviews
udp-glc - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
na 2 udp glc  (Macklin Inc)
86
Macklin Inc na 2 udp glc
Fig. 7. ROS activate the PI3K/AKT pathway, regulating <t>the</t> <t>UGDH-EEF1A2-PRDX1</t> axis to promote chemoresistance. (A) KEGG pathway enrichment of DEGs in UGDH-knockdown SW620 cells (n = 3 replicates). (B) Western blot of PI3K/AKT pathway proteins in HCT8 cells ± LY294002 (10 μM, 48 h, n = 3). (C) PI3K/AKT phosphorylation in HCT8 control and shUGDH cells ± 5-FU (n = 3). (D) UGDH and PI3K/AKT activation in HCT8 cells treated with H2O2 (0–200 μM, 24 h, n = 3). (E) Time-dependent UGDH activation in HCT8 cells treated with 15 μM 5-FU (0–96 h). (n = 3). (F) Western blot of PI3K/AKT pathway proteins in HCT8 cells ± LY294002 (10 μM, n = 3)/± NAC (750 μМ, n = 3). Data are mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
Na 2 Udp Glc, supplied by Macklin Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/udp+glc/2+glc+m+na+udp/pmc12810275-56-10-17
Average 86 stars, based on 1 article reviews
na 2 udp glc - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier
udp glc  (Shanghai Macklin Biochemical)
86
Shanghai Macklin Biochemical udp glc
Fig. 7. ROS activate the PI3K/AKT pathway, regulating <t>the</t> <t>UGDH-EEF1A2-PRDX1</t> axis to promote chemoresistance. (A) KEGG pathway enrichment of DEGs in UGDH-knockdown SW620 cells (n = 3 replicates). (B) Western blot of PI3K/AKT pathway proteins in HCT8 cells ± LY294002 (10 μM, 48 h, n = 3). (C) PI3K/AKT phosphorylation in HCT8 control and shUGDH cells ± 5-FU (n = 3). (D) UGDH and PI3K/AKT activation in HCT8 cells treated with H2O2 (0–200 μM, 24 h, n = 3). (E) Time-dependent UGDH activation in HCT8 cells treated with 15 μM 5-FU (0–96 h). (n = 3). (F) Western blot of PI3K/AKT pathway proteins in HCT8 cells ± LY294002 (10 μM, n = 3)/± NAC (750 μМ, n = 3). Data are mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
Udp Glc, supplied by Shanghai Macklin Biochemical, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/udp+glc/glc+udp/pmc13249509-266-6-15
Average 86 stars, based on 1 article reviews
udp glc - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier
udp glc  (Manan Medical Products Inc)
86
Manan Medical Products Inc udp glc
Fig. 7. ROS activate the PI3K/AKT pathway, regulating <t>the</t> <t>UGDH-EEF1A2-PRDX1</t> axis to promote chemoresistance. (A) KEGG pathway enrichment of DEGs in UGDH-knockdown SW620 cells (n = 3 replicates). (B) Western blot of PI3K/AKT pathway proteins in HCT8 cells ± LY294002 (10 μM, 48 h, n = 3). (C) PI3K/AKT phosphorylation in HCT8 control and shUGDH cells ± 5-FU (n = 3). (D) UGDH and PI3K/AKT activation in HCT8 cells treated with H2O2 (0–200 μM, 24 h, n = 3). (E) Time-dependent UGDH activation in HCT8 cells treated with 15 μM 5-FU (0–96 h). (n = 3). (F) Western blot of PI3K/AKT pathway proteins in HCT8 cells ± LY294002 (10 μM, n = 3)/± NAC (750 μМ, n = 3). Data are mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
Udp Glc, supplied by Manan Medical Products Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/udp+glc/glc+udp/10__1016_slash_j__carpta__2025__100841-255-10-18
Average 86 stars, based on 1 article reviews
udp glc - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

Image Search Results


Fig. 7. ROS activate the PI3K/AKT pathway, regulating the UGDH-EEF1A2-PRDX1 axis to promote chemoresistance. (A) KEGG pathway enrichment of DEGs in UGDH-knockdown SW620 cells (n = 3 replicates). (B) Western blot of PI3K/AKT pathway proteins in HCT8 cells ± LY294002 (10 μM, 48 h, n = 3). (C) PI3K/AKT phosphorylation in HCT8 control and shUGDH cells ± 5-FU (n = 3). (D) UGDH and PI3K/AKT activation in HCT8 cells treated with H2O2 (0–200 μM, 24 h, n = 3). (E) Time-dependent UGDH activation in HCT8 cells treated with 15 μM 5-FU (0–96 h). (n = 3). (F) Western blot of PI3K/AKT pathway proteins in HCT8 cells ± LY294002 (10 μM, n = 3)/± NAC (750 μМ, n = 3). Data are mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.

Journal: Archives of biochemistry and biophysics

Article Title: UGDH promotes 5-fluorouracil resistance in colorectal cancer via the ROS-activated PI3K/AKT-EEF1A2-PRDX1 pathway.

doi: 10.1016/j.abb.2025.110445

Figure Lengend Snippet: Fig. 7. ROS activate the PI3K/AKT pathway, regulating the UGDH-EEF1A2-PRDX1 axis to promote chemoresistance. (A) KEGG pathway enrichment of DEGs in UGDH-knockdown SW620 cells (n = 3 replicates). (B) Western blot of PI3K/AKT pathway proteins in HCT8 cells ± LY294002 (10 μM, 48 h, n = 3). (C) PI3K/AKT phosphorylation in HCT8 control and shUGDH cells ± 5-FU (n = 3). (D) UGDH and PI3K/AKT activation in HCT8 cells treated with H2O2 (0–200 μM, 24 h, n = 3). (E) Time-dependent UGDH activation in HCT8 cells treated with 15 μM 5-FU (0–96 h). (n = 3). (F) Western blot of PI3K/AKT pathway proteins in HCT8 cells ± LY294002 (10 μM, n = 3)/± NAC (750 μМ, n = 3). Data are mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.

Article Snippet: The primary antibodies used were against UGDH (Proteintech), EEF1A2 (Proteintech), PRDX1 (Proteintech), PI3K (CST), phospho-PI3K (CST), Akt (CST), phospho-AKT (Ser473) (CST), FLAG (Proteintech), β-ACTIN (Proteintech), GAPDH (Beyotime), cleaved caspase 3 (CST), and cleaved PARP (CST).

Techniques: Knockdown, Western Blot, Phospho-proteomics, Control, Activation Assay